David Kabanda, a social Rights Lawyer who was among the team that was consulted by local NGO UGANET to conduct the study says the majority of the respondents referred to the new drug as ‘ ‘dolotiya’ to mean dolutegravir but when they were asked why they were shifted, 99% said they don’t know why they had to change their regimens. When they asked health workers, 82% of them didn’t know that patients needed to know other than just receiving the medicine.
